Pipeline Watch: Nine Approvals Plus 29 Phase III Updates
The Week In R&D
Executive Summary
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.